A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma

Pediatric Pulmonology

Volumn 51, Issue 3, 2016, Pages 316-328

  Gomersal, Tim ^a   Harnan, Sue ^a   Essat, Munira ^a   Tappenden, Paul ^a   Wong, Ruth ^a   Lawson, Rod ^b   Pavord, Ian ^c   Everard, Mark Lloyd ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

allergy; asthma and early wheeze; biomarkers; evidence based medicine and outcomes; nitric oxide (NO)

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; FRACTIONAL EXHALED NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG; ANTIASTHMATIC AGENT;

ASTHMA; CLINICAL EFFECTIVENESS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EAR DISEASE; EYE DISEASE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; MEDICATION COMPLIANCE; MORTALITY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NOSE DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SKIN MANIFESTATION; SYSTEMATIC REVIEW; THROAT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; BREATH ANALYSIS; CHILD; DISEASE MANAGEMENT; EXHALATION; METABOLISM;

ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMARKERS; BREATH TESTS; CHILD; DISEASE MANAGEMENT; EXHALATION; HUMANS; NITRIC OXIDE; QUALITY OF LIFE;

EID: 84958159621     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23371     Document Type: Review

References (24)

1. Wadsworth S, Sin D, Dorscheid D., Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy 2011; 4: 77-86.
2. La Grutta S, Ferrante G, Malizia V, Cibella F, Viegi G., Environmental effects on fractional exhaled nitric oxide in allergic children. J Allergy 2012; 2012: 916926.
3. Dodig S, Richter D, Zrinski-Topic R., Inflammatory markers in childhood asthma. Clin Chem Lab Med 2011; 49: 587-599.
4. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD., Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142: 469-475.
5. Smith AD, Cowan JO, Taylor DR,. Exhaled nitric oxide levels in asthma: Personal best versus reference values. J Allergy Clin Immunol 2009; 124: 714-718.
6. Waibel V, Ulmer H, Horak E, Waibel V, Ulmer H, Horak E., Assessing asthma control: symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide. Pediatr Pulmonol 2012; 47: 113-118.
7. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR,. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
8. NICE. Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath. 2014. [accessed 2015 Jun 20] https://www.nice.org.uk/guidance/dg12/resources/measuring-fractional-exhaled-nitric-oxide-concentration-in-asthma-niox-mino-niox-vero-and-nobreath-1053626430661
9. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB., Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009; 4: CD006340.
10. CRD. 2009. Systematic reviews: CRD's guidance for undertaking reviews in health care. 1 ed. York: Centre for Reviews and Dissemination.
11. Higgins JPT, Green S., 2008. Cochrane handbook for systematic reviews of interventions. 1 ed. Wiley.
12. Fritsch M, Uxa S, Horak F, Jr., Putschoegl B, Dehlink E, Szepfalusi Z, Frischer T., Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006; 41: 855-862.
13. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, et al., Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372: 1065-1072.
14. Verini M, Consilvio NP, Di Pillo S, Cingolani A, Spagnuolo C, Rapino D, Scaparrotta A, Chiarelli F., FeNO as a marker of airways inflammation: the possible implications in childhood asthma management. J Allergy 2010.
15. Pijnenburg MW, Bakker EM, Hop WC, de Jongste JC., Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172: 831-836.
16. Peirsman EJ, Carvelli TJ, Hage PY, Hanssens LS, Pattyn L, Raes MM, Sauer KA, Vermeulen F, Desager KN., Exhaled nitric oxide in childhood allergic asthma management a randomised controlled trial. Pediatr Pulmonol 2013; 49: 624-631.
17. Petsky HL, Li AM, Au CT, Kynaston JA, Turner C, Chang AB., Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: a dual centre randomized controlled trial. Pediatr Pulmonol 2014; 50: 535-543.
18. Pike K, Selby A, Price S, Warner J, Connett G, Legg J, Lucas JSA, Peters S, Buckley H, Magier K, et al., Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. Clin Respir J 2013; 7: 204-213
19. Pijnenburg MW, Lissenberg ET, Hofhuis W, Ghiro L, Hop WC, Holland WP, de Jongste JC., Exhaled nitric oxide measurements with dynamic flow restriction in children aged 4-8 yrs. Eur Respir J 2002; 20: 919-924.
20. Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, Gibson PG., Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011; 378: 983-990.
21. Gibson PG., Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for asthma treatment algorithm studies. Clin Exp Allergy 2009; 39: 478-490.
22. de Jongste JC, Carraro S, Hop WC, Baraldi E., Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179: 93-97.
23. Lu M, Wu B, Che D, Qiao R, Gu H., FeNO and asthma treatment in children: a systematic review and meta-analysis. Medicine 2015; 94: e347.
24. Turner S., Exhaled nitric oxide and the management of childhood asthma-yet another promising biomarker "has been" or a misunderstood gem. Paediatr Respir Rev 2015; 16: 88-96.